Welcome to today's Medical News Today News Alert containing today's medical news headlines for your chosen categories. You will only receive these alerts when new news is available for your chosen categories.
To unsubscribe from our news alerts, or to alter any of your subscription details (name,e-mail address etc) please see
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .
----------------------------------------------
** BREAST CANCER News **
No news for this category today.
----------------------------------------------
** CANCER / ONCOLOGY News **
Chicago Sun-Times Columnist Discusses Oral Health Among Black Men
http://www.medicalnewstoday.com/articles/118792.php
<a href="http://www.suntimes.com/news/mitchell/1114373,CST-NWS-mitch19.article" target="_new"><cite>Chicago</cite> <cite>Sun-Times</cite></a> columnist Mary Mitchell on Tuesday discussed the efforts of two young black dentists in Chicago who are seeking to improve the oral health of black men.
The Lance Armstrong Foundation Receives CEO Cancer Gold StandardTM Accreditation
http://www.medicalnewstoday.com/articles/118781.php
Today, the Lance Armstrong Foundation (LAF) was accredited with the <i>CEO Cancer Gold Standard</i>™ certification, recognizing the organization's commitment to the health of their employees and family members by certifying their efforts to meet an exceptionally high standard of cancer prevention, screening and care guidelines.
Enzyme That Sensitizes Cells To Chemotherapeutics Could Also Be New Anti-cancer Target
http://www.medicalnewstoday.com/articles/118760.php
Researchers at Van Andel Institute (VAI) and Novartis Institutes for Biomedical Research have identified an important enzyme required for cancer cell survival. Lowering levels of the enzyme caused a wide variety of cancer cells to die, reduced proliferation of cancer cells, and sensitized cancer cells to commonly used chemotherapeutic agents, such as the drug Taxol.
Food, Health Get Top Billing At National Chemistry Meeting
http://www.medicalnewstoday.com/articles/118716.php
Well beyond the advice to drink enough H2O and not eat too much NaCl, the nation's chemists will get elemental with grapefruit, onions, peppers, tomatoes, carrots and watermelons this week at the American Chemical Society meeting.
New Imaging Technique For More Precise Cancer Surgery
http://www.medicalnewstoday.com/articles/118712.php
Cancer surgeons today operate "blind" with no clear way of determining in real-time whether they have removed all of the diseased tissue, which is the key to successful surgery. Researchers in Massachusetts now report development and early clinical trials of a new imaging system that highlights cancerous tissue in the body so that surgeons can more easily see and remove diseased tissue with less damage to normal tissue near the tumor.
Bowel Cancer Indicator Should Lead To Better Treatment
http://www.medicalnewstoday.com/articles/118648.php
STEM cell scientists have developed a more accurate way of identifying aggressive forms of bowel cancer, which should eventually lead to better treatment and survival rates. The UK-led team, headed by scientists from Durham University and the North East England Stem Cell Institute, (NESCI*), studied tissue samples from 700 colorectal cancer patients and tracked their progress.
----------------------------------------------
** CERVICAL CANCER / HPV VACCINE News **
No news for this category today.
----------------------------------------------
** COLORECTAL CANCER News **
Stem Cell Marker For Aggressive Bowel Cancer
http://www.medicalnewstoday.com/articles/118861.php
UK scientists have found a more accurate way to detect aggressive bowel cancers using a stem cell marker protein; they hope that the new development will improve treatment and survival for thousands of patients.
Chew Gum After Colon Surgery For Faster Recovery
http://www.medicalnewstoday.com/articles/118554.php
A meta-analysis published in the August issue of <i>Archives ofSurgery</i> concludes that patients who have surgery to removeall or part of the colon (colectomy) have enhanced recovery ofintestinal function if they chew gum.
----------------------------------------------
** LUNG CANCER News **
Enzyme That Sensitizes Cells To Chemotherapeutics Could Also Be New Anti-cancer Target
http://www.medicalnewstoday.com/articles/118760.php
Researchers at Van Andel Institute (VAI) and Novartis Institutes for Biomedical Research have identified an important enzyme required for cancer cell survival. Lowering levels of the enzyme caused a wide variety of cancer cells to die, reduced proliferation of cancer cells, and sensitized cancer cells to commonly used chemotherapeutic agents, such as the drug Taxol.
----------------------------------------------
** LYMPHOMA / LEUKEMIA News **
Vion Pharmaceuticals Enters Into Agreement With HOVON To Conduct A Phase III Clinical Trial Of Cloretazine(R)
http://www.medicalnewstoday.com/articles/118738.php
VION PHARMACEUTICALS, INC. (Pink Sheets: VION) announced that it had entered into an agreement with the Dutch-Belgian Cooperative Trial Group for Hematology Oncology (the "HOVON") to conduct a clinical trial of laromustine (Cloretazine(R) (VNP40101M)) with standard remission-induction therapy in patients aged 18-65 with previously untreated acute myelogenous leukemia (AML) and high-risk myelodysplasia (MDS).
----------------------------------------------
** PROSTATE / PROSTATE CANCER News **
Obese Prostate Cancer Patients May Benefit More From Brachytherapy
http://www.medicalnewstoday.com/articles/118725.php
Brachytherapy, also called seed implants, may be a more beneficialtreatment than surgery or external beam radiation therapy for overweight or obese prostate cancer patients,according to a study published in the August issue of the <i>International Journal of RadiationOncology*Biology*Physics</i>, the official journal of the American Society for Therapeutic Radiology andOncology.
Total And Free PSA (PSA/fPSA) Assays Now Available For The Olympus AU3000i Immunoassay Analyser
http://www.medicalnewstoday.com/articles/118720.php
Olympus is pleased to announce the launch of highly sensitive and precise PSA (Prostate Specific Antigen) and fPSA assays for the Olympus AU3000i immunoassay analyser. The use of PSA and fPSA is well established in the screening and management of prostate cancer.
-------------------------------------------------------------
You are receiving this news alert e-mail because you subscribed via an online form on our web site. If you wish to unsubscribe, please visit
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .
No comments:
Post a Comment